Jane Street’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-14,500
Closed -$88K 11227
2021
Q3
$88K Buy
+14,500
New +$90.4K ﹤0.01% 9357

Jane Street's FLXN Position: Q4 2021 in Review

Jane Street sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2021, closing a stake of 25,108 shares — an estimated $153K sold.

Jane Street first reported a position in FLXN in Q3 2015 and held it in 10 quarters. The position peaked at $1.72M in Q1 2021. 1 fund tracked by Wall St. Rank holds FLXN as of Q4 2021.

  • Jane Street reported no remaining Flexion Therapeutics, Inc. position as of Q4 2021 after selling out during the quarter.
  • Jane Street sold 25,108 Flexion Therapeutics, Inc. shares in Q4 2021, an estimated $153K.
  • Jane Street first reported a position in Flexion Therapeutics, Inc. in Q3 2015 and held it in 10 quarters.
  • Jane Street's Flexion Therapeutics, Inc. position peaked at $1.72M in Q1 2021.
  • 1 fund tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2021.

Based on Jane Street's 13F filing for Q4 2021, filed 15 Feb 2022.